Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE
about
Autoimmune-mediated reduction of high-density lipoprotein-cholesterol and paraoxonase 1 activity in systemic lupus erythematosus-prone gld mice.Inflammation-mediated rheumatic diseases and atherosclerosisPathogenesis of atherosclerosis: A multifactorial process.G2A and LPC: regulatory functions in immunity.Autoantibodies to posttranslational modifications in rheumatoid arthritis.Identification of a plasma signature of psychotic disorder in children and adolescents from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort.Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.Liposomes assembled from a dual drug-tailed phospholipid for cancer therapy.
P2860
Q34546651-977C71B1-4A4F-406D-A85D-E636D5D593CDQ35549285-F69FD417-7168-4949-A713-3D7D4D725215Q37276377-86B337C2-5223-4D77-B8B3-7290373577B7Q37339837-220B77F6-30EA-45B7-8CB5-FD937390F116Q37693939-334BC5F5-F638-4C08-BDE0-F414D855C333Q42257121-57DB51FD-6E41-4E9F-9103-2D843ED37536Q44183283-09BFAB32-8D26-4B4C-B1CF-21C2B702EDB9Q51007292-262F852C-1C5D-401D-BB30-97937CF3464E
P2860
Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE
description
im Januar 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 January 1999
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 1999
@uk
name
Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE
@en
Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE
@nl
type
label
Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE
@en
Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE
@nl
prefLabel
Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE
@en
Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE
@nl
P2093
P2860
P50
P1433
P1476
Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE
@en
P2093
P2860
P304
P356
10.1191/096120399678847434
P577
1999-01-01T00:00:00Z